查找临床试验
已按「帕金森病」检索，对应国际通用词 Parkinson disease
共找到 12 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 09:55，每 5 分钟自动同步A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSA
China
年龄 18 Years – 不限
Synusight Biotech (Shanghai) Co., Ltd.
AR Gait Training for Parkinson's Disease
Taiwan
年龄 20 Years – 不限
Chang Gung University
Influence of Autonomy on Motor Learning in People With Parkinson's Disease
Taiwan
年龄 20 Years – 不限
National Taiwan University Hospital
Impact of Force Control of Hip Abductor Muscles in Healthy Adults and Individuals With Parkinson's Disease
Taiwan
年龄 20 Years – 85 Years
Chang Gung Memorial Hospital
The Efficacy and Safety of Precision REpetitive Transcranial Magnetic Stimulation in Alleviating Motor Symptom in Parkinson's Disease
China
年龄 40 Years – 不限
Anhui Medical University
Different Frequency Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease
China
年龄 不限 – 不限
Ke Dong, MD
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
United States、Hungary、Israel、Italy、Poland 等 9 国
年龄 18 Years – 不限
Merck Sharp & Dohme LLC
Integrated Digital and Neurogenic Exosome Biomarkers for Early Diagnosis of Parkinson's Disease: Development and Application
China
年龄 40 Years – 80 Years
Fujian Medical University Union Hospital
Artificial Intelligence-assisted MDS-UPDRS Assessment for Parkinson's Disease
China、Hong Kong
年龄 18 Years – 95 Years
Hong Kong University of Science and Technology
VIM+PTT MRgFUS for PD
China
年龄 22 Years – 不限
Chinese PLA General Hospital
SCAN Targeted Epidural Modulation for Parkinson's Disease
China
年龄 40 Years – 75 Years
Changping Laboratory
The Safety and Tolerability of XS411CN Injection in Treatment of Primary Parkinson's Disease
China
年龄 50 Years – 75 Years
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.